What Are You Looking For?
High-Purity Arglabin (≥98%) CAS 84692-91-1 | Bulk Supply for Pharma/Research
Arglabin (CAS 84692-91-1) is a bioactive sesquiterpene lactone primarily isolated from Artemisia species (e.g., Artemisia glabella) and Tanacetum parthenium (feverfew). As a potent farnesyltransferase inhibitor, it targets RAS oncogene activation pathways, demonstrating significant antitumor effects.
Product Name :
ArglabinCAS No. :
84692-91-1Appearance :
White to off-white crystalline powderSpecification :
98%CAS No.: 84692-91-1
Molecular Formula: C₁₅H₁₈O₃
Molecular Weight: 246.30
Potent NLRP3 Inflammasome Inhibitor with Dual Anticancer & Anti-Atherogenic Activity
≥98% Pure: White to off-white crystalline powder (HPLC-Validated Pharma Grade)
Mechanism-Confirmed Benefits:
Anti-Inflammatory Action
Anticancer Activity
Cardiometabolic Protection
Immunomodulatory Effects
Parameter | Detail |
---|---|
Purity | ≥98% (HPLC-ELSD) |
Identification | HPLC-UV/ELSD, ¹³C-NM |
Solubility | Soluble in DMSO (95 mg/mL), ethanol; insoluble in water (<0.1 g/L) |
Melting Point | 100-102°C |
Density | 1.22 g/cm³ (20°C) |
Storage | 2–8°C (desiccated, amber glass; avoid light) |
Shelf Life | 24 months |
Industry | Use Cases |
---|---|
Pharmaceuticals | - Targeted therapies for NLRP3-driven diseases (e.g., atherosclerosis, gout) - RAS-mutated cancer adjuvants |
Immunology Research | - Inflammasome mechanism studies - Macrophage polarization modulators |
Nutraceuticals | - Anti-atherogenic supplements for metabolic syndrome |
Veterinary | - Chronic inflammation management in companion animals |
Dual-Pathway Modulation
Sustainable Sourcing
Clinical Evidence
Regulatory Compliance
Goods weight |
Packing |
Shipping method |
Lead-time |
5 mg-20mg |
Amber glass vials (argon-flushed) |
Dry ice express |
3~5 days after your payment |
20mg-1 g |
Vacuum-sealed foil bags (O₂ absorber) |
Air shipping | 3~5 days after your payment |
>1 g |
Nitrogen-purged steel drums |
Air shipping |
5~7 days after your payment |
Q1: Could you provide free samples for test?